Your browser doesn't support javascript.
loading
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial.
Nowbar, Alexandra N; Rajkumar, Christopher; Foley, Michael; Ahmed-Jushuf, Fiyyaz; Howard, James P; Seligman, Henry; Petraco, Ricardo; Sen, Sayan; Nijjer, Sukhjinder S; Shun-Shin, Matthew J; Keeble, Thomas R; Sohaib, Afzal; Collier, David; McVeigh, Patrick; Harrell, Frank E; Francis, Darrel P; Al-Lamee, Rasha K.
Afiliação
  • Nowbar AN; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Rajkumar C; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Foley M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Ahmed-Jushuf F; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Howard JP; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Seligman H; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Petraco R; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Sen S; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Nijjer SS; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Shun-Shin MJ; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Keeble TR; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Sohaib A; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Collier D; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • McVeigh P; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Harrell FE; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Francis DP; Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom.
  • Al-Lamee RK; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
EuroIntervention ; 17(18): 1490-1497, 2022 Apr 22.
Article em En | MEDLINE | ID: mdl-35156616
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Angina Estável / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Cardiovasculares / Angina Estável / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Guideline Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article